Artiva Biotherapeutics logo

Artiva Biotherapeutics Share Price (NASDAQ: ARTV)

$3.17

0.01

(0.32%)

Last updated on

Check the interactive Artiva Biotherapeutics Stock chart to analyse performance

Artiva Biotherapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$3.15
    Today's High:$3.21

    Day's Volatility :1.87%

  • 52 Weeks Low:$1.47
    52 Weeks High:$17.31

    52 Weeks Volatility :91.51%

Artiva Biotherapeutics Stock Returns

PeriodArtiva Biotherapeutics IncIndex (Russel 2000)
3 Months
63.4%
0.0%
6 Months
-19.13%
0.0%
1 Year
-71.21%
0.0%
3 Years
-73.58%
-4.1%

Artiva Biotherapeutics Inc Key Stats

Check Artiva Biotherapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.16
Open
$3.21
Today's High
$3.21
Today's Low
$3.15
Market Capitalization
$77.2M
Today's Volume
$35.2K
52 Week High
$17.31
52 Week Low
$1.47
Revenue TTM
$0.0
EBITDA
$-79.1M
Earnings Per Share (EPS)
$-6.15
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-86.18%

Stock Returns calculator for Artiva Biotherapeutics Stock including INR - Dollar returns

The Artiva Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Artiva Biotherapeutics investment value today

Current value as on today

₹34,076

Returns

₹65,924

(-65.92%)

Returns from Artiva Biotherapeutics Stock

₹71,208 (-71.21%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Artiva Biotherapeutics Stock

-33%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Artiva Biotherapeutics Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Artiva Biotherapeutics Stock

Rating
Trend

Artiva Biotherapeutics Share Price Target

What analysts predicted

Upside of 385.8%

Target:

$15.40

Current:

$3.17

Artiva Biotherapeutics share price target is $15.40, a slight Upside of 385.8% compared to current price of $3.17 as per analysts' prediction.

Artiva Biotherapeutics Stock Insights

  • Price Movement

    In the last 7 days, ARTV stock has moved up by 10.1%
  • ARTV vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 142.4%

Artiva Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Artiva Biotherapeutics is currently in a neutral trading position according to technical analysis indicators.

Artiva Biotherapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Artiva Biotherapeutics Inc logo
12.01%
-19.13%
-71.21%
-73.58%
-73.58%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Artiva Biotherapeutics Inc

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, and B-cell-non-Hodgkin lymphoma. It also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 targeting chimeric antigen receptor (CAR)-NK cell product candidate for the treatment of various solid tumors, such as breast, gastric and esophageal, and bladder cancers; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate for the treatment of hematological malignancies. Artiva Biotherapeutics, Inc. was incorporated in 2019 and is headquartered in San Diego, California.
Organization
Artiva Biotherapeutics
Employees
105
CEO
Dr. Fred Aslan M.D.
Industry
Miscellaneous

Key Management of Artiva Biotherapeutics Inc

NameTitle
Dr. Fred Aslan M.D.
President, CEO & Director
Ms. Neha Krishnamohan
CFO & Executive VP of Corporate Development
Ms. Jennifer Kinsbruner Bush Esq., J.D.
Executive VP, COO, Chief Legal Officer, Corporate Secretary & Compliance Officer
Dr. Peter Flynn Ph.D.
Co-Founder & Strategic Advisor
Mr. Christopher P. Horan
Chief Technical Operations Officer
Dr. Heather Raymon Ph.D.
Senior Vice President of Research & Early Development
Dr. David Moriarty Ph.D.
Senior VP of Clinical Operations
Mr. Benjamin Dewees
Senior Vice President of Regulatory Affairs
Mr. Feng Xu
Senior Vice President of Biometrics
Dr. Subhashis Banerjee M.D.
Chief Medical Officer

Important FAQs about investing in ARTV Stock from India :

What is Artiva Biotherapeutics share price today?

Artiva Biotherapeutics share price today is $3.17 as on at the close of the market. Artiva Biotherapeutics share today touched a day high of $3.21 and a low of $3.15.

What is the 52 week high and 52 week low for Artiva Biotherapeutics share?

Artiva Biotherapeutics share touched a 52 week high of $17.31 and a 52 week low of $1.47. Artiva Biotherapeutics stock price today i.e. is closed at $3.17, lower by 81.69% versus the 52 week high.

How to invest in Artiva Biotherapeutics Stock (ARTV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Artiva Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Artiva Biotherapeutics Shares that will get you 0.4732 shares as per Artiva Biotherapeutics share price of $3.17 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Artiva Biotherapeutics Stock (ARTV) from India?

Indian investors can start investing in Artiva Biotherapeutics (ARTV) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Artiva Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Artiva Biotherapeutics share’s latest price of $3.17 as on August 30, 2025 at 1:29 am IST, you will get 3.1546 shares of Artiva Biotherapeutics. Learn more about fractional shares .

What are the returns that Artiva Biotherapeutics has given to Indian investors in the last 5 years?

Artiva Biotherapeutics stock has given -73.58% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?